NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘VersaPharm’

12 May 2014

Tailwind set for VersaPharm exit as Akorn agrees $440m buyout

pharma_lrg Tailwind Capital-backed drug maker VersaPharm is set to be bought by Akorn in a $440m all-cash deal.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014